<html>
	<head>
		<title>microbio <mrc> plans acquisition, financing</title>
		<meta name="keywords" content="topics acq">
		<meta name="keywords" content="places usa">
</head>
<body>
	<h3>microbiological research corp said it entered into a letter of intent for a proposed business combination with privately owned <datagene scientific laboratories inc>, and <milex corp> a newly formed company, through a stock swap.     it also said it received 100,000 dlrs from the sale of a convertible note to ventana growth fund as part of an overall 1,100,000 equity financing plan with ventana. under that plan, a minimum of 400,000 dlrs and a maximum of one mln dlrs of additional new capital is to be provided to fund the combined operations of the three companies.     microbiological also said that if the maximum additional capital is raised, it will own about 49 pct of 4,550,00 shares of common outstanding in the new combined company, datagene holders will own 29 pct, and ventana and others will own 13 pct.     it said the remaining nine pct will be held by milex shareholder norman monson, who will become chief executive officer of the combined companies.  reuter &#3;</h3>
</body>
</html>